Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
23 Mai 2022 - 05:45PM
Business Wire
Regulatory News:
The shareholders of Median Technologies (ALMDT:PA) are invited
to participate at the Shareholders’ Ordinary and Extraordinary
General Meeting which will be held on Tuesday June 14, 2022, at
5:00 PM at PDGB, 174 avenue Victor Hugo – 75116 Paris.
All useful information relating to this Shareholders’ General
Meeting is regularly updated on Median Technologies’ website.
Shareholders may exercise their voting rights before the holding
of the Shareholders’ General Meeting, either by returning their
postal voting form, or by giving proxy. The detailed procedures
relating to the exercise of the right to vote are specified in the
notice of the Shareholders’ General Meeting, available here on
Median’s website
The preliminary notice of the Shareholders’ General Meeting has
been published in the BALO (Bulletin des annonces légales
obligatoires) on May 6, 2022.
The documents referred to in Article R.225-83 of the French
Commercial Code are made available to Shareholders as from the date
of the convening notice for the Meeting in accordance with
applicable regulations:
- Registered shareholders may, up to and including the fifth day
prior to the Meeting, request that the company sends these
documents to them free of charge. For shareholders holding bearer
shares, the exercise of this right is subject to the provision of a
certificate of registration in the accounts of the bearer shares
issued by the authorized intermediary;
- Shareholders may consult these documents at the company’s
registered office, Les 2 Arcs, 1800 route des Crêtes – 06560
Valbonne, under the conditions provided for by applicable
regulations.
The documents to be communicated within the context of the
Shareholders’ General Meeting may be consulted and downloaded on
Median Technologies’ website under the “Shareholder Meetings”
section here.
About Median Technologies: About Median Technologies: Median
Technologies provides innovative imaging solutions and services to
advance healthcare for everyone. We harness the power of medical
images by using the most advanced Artificial Intelligence
technologies, to increase the accuracy of diagnosis and treatment
of many cancers and other metabolic diseases at their earliest
stages and provide insights into novel therapies for patients. Our
iCRO solutions for medical image analysis and management in
oncology trials and iBiopsy®, our AI-powered software as medical
device help biopharmaceutical companies and clinicians to bring new
treatments and diagnose patients earlier and more accurately. This
is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median
is eligible for the French SME equity savings plan scheme
(PEA-PME), is part of the Enternext® PEA-PME 150 index and has been
awarded the Euronext European Rising Tech label. For more
information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220523005724/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024